Agios Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results and Business Highlights

Agios Pharmaceuticals will host a conference call on October 30, 2025, to discuss Q3 financial results and updates.

Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.

$AGIO Congressional Stock Trading

Members of Congress have traded $AGIO stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $AGIO stock by members of Congress over the last 6 months:

• REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 04/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$AGIO Insider Trading Activity

$AGIO insiders have traded $AGIO stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.

Here’s a breakdown of recent trading of $AGIO stock by insiders over the last 6 months:

• BRIAN GOFF (Chief Executive Officer) has made 0 purchases and 3 sales selling 29,785 shares for an estimated $1,033,684.
• SARAH GHEUENS (Chief Medical Officer) has made 0 purchases and 4 sales selling 18,914 shares for an estimated $689,958.
• THEODORE JAMES JR. WASHBURN (Principal Accounting Officer) sold 8,546 shares for an estimated $315,091
• CECILIA JONES (Chief Financial Officer) has made 0 purchases and 2 sales selling 5,431 shares for an estimated $193,948.
• JAMES WILLIAM BURNS (Chief Legal Officer) sold 2,799 shares for an estimated $93,878
• TSVETA MILANOVA (Chief Commercial Officer) sold 2,770 shares for an estimated $92,905
• DAVID SCADDEN has made 0 purchases and 3 sales selling 1,800 shares for an estimated $72,200.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AGIO Hedge Fund Activity

We have seen 105 institutional investors add shares of $AGIO stock to their portfolio, and 102 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• PARADIGM BIOCAPITAL ADVISORS LP added 1,142,511 shares (+inf%) to their portfolio in Q2 2025, for an estimated $37,999,915
• POLAR CAPITAL HOLDINGS PLC removed 1,002,036 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $33,327,717
• ARMISTICE CAPITAL, LLC removed 880,000 shares (-43.0%) from their portfolio in Q2 2025, for an estimated $29,268,800
• TCG CROSSOVER MANAGEMENT, LLC added 697,003 shares (+inf%) to their portfolio in Q2 2025, for an estimated $23,182,319
• ROCK SPRINGS CAPITAL MANAGEMENT LP added 647,565 shares (+189.2%) to their portfolio in Q2 2025, for an estimated $21,538,011
• STATE STREET CORP removed 498,366 shares (-20.3%) from their portfolio in Q2 2025, for an estimated $16,575,653
• WELLINGTON MANAGEMENT GROUP LLP added 397,667 shares (+1625.7%) to their portfolio in Q2 2025, for an estimated $13,226,404

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AGIO Analyst Ratings

Wall Street analysts have issued reports on $AGIO in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Scotiabank issued a "Sector Outperform" rating on 07/28/2025
• B of A Securities issued a "Buy" rating on 07/22/2025

To track analyst ratings and price targets for $AGIO, check out Quiver Quantitative's $AGIO forecast page.

$AGIO Price Targets

Multiple analysts have issued price targets for $AGIO recently. We have seen 3 analysts offer price targets for $AGIO in the last 6 months, with a median target of $56.0.

Here are some recent targets:

• Emily Bodnar from HC Wainwright & Co. set a target price of $56.0 on 09/04/2025
• Greg Harrison from Scotiabank set a target price of $65.0 on 07/28/2025
• Greg Harrison from B of A Securities set a target price of $51.0 on 07/22/2025